Through our Investigator Initiated Trials (IIT) program, Alkermes supports investigator sponsored research on VIVITROL® (naltrexone for extended-release injectable suspension).
In an IIT, the investigator, as the study sponsor, assumes responsibility for all aspects of the research, including:
Investigators who are awarded support through Alkermes’ IIT program will be required to submit a final study report/summary to Alkermes at the conclusion of the study.
Alkermes is currently prioritizing review of projects which request a supply of VIVITROL and/or placebo for VIVITROL. If you are an investigator looking to submit a project proposal requesting VIVITROL and/or placebo for VIVITROL, please email IIT@Alkermes.com for an application. Please note that a submission of proposal does not guarantee Alkermes support.